interest
read
articl
abha
sahni
cowork
vecadherin
bind
domain
fibrinogen
induc
endotheli
barrier
permeabl
enhanc
transendotheli
migrat
malign
breast
epitheli
cell
edit
august
sahni
et
al
show
addit
intact
fibrinogen
induc
increas
endotheli
permeabl
increas
shown
mediat
via
bind
fibrinogen
domain
b
vecadherin
endotheli
cell
transendotheli
migrat
malign
breast
cancer
cell
increas
fibrinogen
data
provid
novel
insight
transendotheli
migrat
malign
cell
requir
fibrinogen
domain
b
vecadherin
bind
sahni
et
al
show
significantli
increas
permeabl
human
endotheli
cell
use
nm
gl
fibrinogen
surpris
find
sinc
fibrinogen
concentr
human
circul
experi
nm
intact
fibrinogen
show
increas
permeabl
endotheli
monolay
use
highli
purifi
intact
fibrinogen
fraction
unpublish
publish
data
higher
fibrinogen
concentr
show
consensu
whether
intact
protein
increas
vascular
permeabl
tyagi
et
al
show
patholog
high
level
fibrinogen
lm
increas
permeabl
endotheli
monolay
wherea
physiolog
concentr
lm
effect
sahni
et
al
show
induct
endotheli
permeabl
use
nm
fibrinogen
refer
human
circul
would
surpris
fibrinogen
concentr
beneath
physiolog
level
would
abl
increas
permeabl
therefor
care
compar
experi
propos
mechan
fibrinogeninduc
permeabl
investig
use
peptid
block
antibodi
sahni
et
al
show
impair
fibrinogeninduc
permeabl
addit
antibodi
excess
suggest
antibodi
bound
intact
fibrinogen
therebi
impair
endotheli
permeabl
howev
kudryk
et
al
show
monoclon
antibodi
bind
b
fibrin
degrad
product
wherea
bind
intact
fibrinogen
shown
time
lower
moreov
peptid
b
shown
mimic
fibrinogeninduc
permeabl
control
peptid
effect
state
introduct
domain
b
cryptic
fibrinogen
expos
cleavag
fibrinopeptid
b
proteolyt
degrad
domain
b
also
expos
thrombinindepend
fibrinogen
matrix
assembl
method
articl
describ
intact
solubl
fibrinogen
ad
apic
side
endotheli
monolay
question
rise
whether
fibrinogen
domain
b
expos
bound
endotheli
vecadherin
increas
permeabl
role
vecadherin
regul
permeabl
endotheli
cell
junction
extens
studi
moreov
shown
ge
et
al
rel
low
concentr
fibrin
degrad
product
increas
endotheli
permeabl
shown
lm
gl
fragment
caus
doubl
transendotheli
ialbumin
clearanc
hr
healthi
individu
ddimer
concentr
maximum
gl
taken
togeth
find
strongli
suggest
presenc
fibrin
monom
fibrin
degrad
product
fibrinogen
sampl
use
sahni
et
al
altern
exposur
cryptic
domain
within
fibrinogen
molecul
conform
chang
may
contribut
exposur
fibrin
specif
epitop
also
observ
fibrinogen
bind
plastic
cultur
plate
mechan
propos
sahni
et
al
tumorassoci
fibrinogen
facilit
transendotheli
migrat
malign
cell
intact
fibrinogen
would
increas
vascular
permeabl
via
bind
fibrinogen
domain
b
endotheli
vecadherin
howev
domain
b
shown
cryptic
intact
fibrinogen
opinion
intact
fibrinogen
fibrin
degrad
product
respons
observ
effect
shed
new
light
data
palumbo
et
al
show
fibrin
ogen
import
determin
metastat
potenti
tumor
cell
wildtyp
mice
reduct
tumor
metastasi
seen
addit
thrombininhibitor
hirudin
addit
contribut
fibrinogen
plateletmicrothrombi
may
provid
protect
tumor
cell
innat
immun
surveil
system
sahni
et
al
propos
tumorassoci
fibrinogen
facilit
transendotheli
migrat
malign
cell
addit
latter
propos
mechan
would
tumorassoci
fibrinogen
convert
fibrin
monom
fibrin
degrad
product
thereaft
act
bridg
molecul
tumor
cell
endotheli
cell
transendotheli
migrat
take
place
bridg
fibrin
vecadherin
endotheli
cell
mediat
via
domain
b
molecul
summari
find
demonstr
rel
low
concentr
intact
fibrinogen
increas
permeabl
reconsid
domain
b
expos
thrombin
cleavag
degrad
fibrin
thereaft
fibrin
specif
antibodi
bind
result
shown
sahni
et
al
strongli
suggest
presenc
fibrin
specif
epitop
bear
impact
interpret
data
view
intact
fibrinogen
fibrin
monom
fibrin
degrad
product
form
bridg
molecul
tumor
endotheli
cell
moreov
appreci
concern
rais
weijer
et
al
effect
observ
endotheli
permeabl
malign
breast
epitheli
cell
transendotheli
cell
migrat
due
thrombinproteolyt
convers
exogen
ad
fibrinogen
fibrin
monom
andor
fibrin
ogen
degrad
product
due
exposur
cryptic
vascular
endotheli
cadherin
bind
domain
locat
residu
b
chain
intact
fibrinogen
although
role
vecadherin
regul
endotheli
cell
permeabl
well
establish
role
intact
fibrinogen
absenc
convers
fibrin
andor
fibrin
ogen
degrad
product
promot
endotheli
cell
permeabl
would
unexpect
initi
studi
also
expect
fibrin
monom
fibrin
ogen
degrad
product
previous
report
literatur
cite
weijer
etal
would
induc
permeabl
barrier
endothelium
commerci
purchas
highli
purifi
fibrinogen
use
studi
subject
addit
rigor
qualiti
control
describ
although
small
amount
fibrin
fibrin
ii
well
fibrin
ogen
degrad
product
found
commerci
sourc
purifi
human
fibrinogen
prepar
pool
plasma
convinc
neglig
contamin
fibrin
monom
andor
fibrin
ogen
degrad
product
account
effect
observ
weijer
et
al
rais
possibl
intact
fibrinogen
convert
fibrin
thrombin
ad
condit
medium
cultur
endotheli
cell
address
concern
show
addit
data
collect
control
experi
cours
studi
fig
determin
whether
thrombin
activ
affect
permeabl
induc
intact
fibrinogen
assess
fitcdextran
flux
across
endotheli
barrier
describ
absenc
presenc
specif
thrombin
inhibitor
hirudin
shown
figur
unitml
hirudin
effect
flux
fitcdextran
across
endotheli
barrier
p
student
ttest
indic
activ
thrombin
particip
fibrinogeninduc
endotheli
permeabl
higher
concentr
hirudin
unitsml
also
effect
endotheli
barrier
permeabl
unpublish
data
address
suggest
solubl
intact
fibrinogen
convert
fibrin
andor
fibrin
ogen
degrad
product
malign
breast
epitheli
cell
show
data
collect
dr
brian
rybarczyk
publish
doctor
dissert
iodin
fibrinogen
expos
cell
hr
remain
intact
kda
cleav
thrombin
crosslink
form
fibrin
ogen
polym
typic
proteolyt
degrad
product
eg
plasminderiv
fragment
e
observ
fig
data
publish
laboratori
indic
fibrinogen
ad
exogen
fibroblast
pleas
see
fig
ref
endogen
produc
lung
epitheli
cell
pleas
see
fig
ref
remain
intact
addit
data
laboratori
suggest
cellassoci
fibrinogen
interact
cell
surfac
integrin
either
directli
indirectli
associ
fibronectin
cell
surfac
heparan
sulfat
proteoglycan
hspg
wide
accept
other
us
residu
defin
fibrinogenb
cryptic
intact
fibrinogenth
fibrinspecif
monoclon
antibodi
bind
epitop
defin
residu
b
intact
fibrinogen
present
either
solut
adsorb
solid
surfac
howev
shown
highli
purifi
intact
fibrinogen
ad
solut
phase
metabol
activ
cell
cultur
fibrinogen
assembl
extracellular
matrix
absenc
proteolyt
cleavag
fibrin
fibrin
ogen
degrad
product
process
higher
order
structur
coval
crosslink
fibrin
ogen
observ
use
primari
cell
human
foreskin
fibroblast
human
umbil
vein
endotheli
cell
well
human
cell
line
includ
lung
type
iilik
epitheli
cell
nonmalign
malign
breast
epitheli
cell
moreov
shown
conclus
b
expos
fibrillar
matrix
fibrinogen
recogn
monoclon
antibodi
fig
reproduc
permiss
blood
cover
photo
palumbo
et
al
perform
eleg
experi
mutant
mice
show
plasma
fibrin
ogen
thrombin
platelet
import
promot
metastasi
certain
letter
editor
cancer
lung
pertin
respons
result
show
fibrinogendefici
mice
number
metastat
foci
melanoma
lewi
lung
carcinoma
greatli
reduc
lung
weijer
et
al
rais
point
palumbo
colleagu
perform
experi
absenc
presenc
specif
thrombin
inhibitor
hirudin
lung
metastasi
reduc
hirudintr
wildtyp
mice
pleas
see
fig
ref
howev
hirudin
also
decreas
lung
metastasi
compar
fibrinogendefici
mice
pleas
see
fig
ref
suggest
prometastat
affect
thrombin
part
fibrinogen
independ
well
known
thrombin
contribut
sever
cancer
progress
promot
tumor
angiogenesi
cancer
cell
prolifer
metastasi
mechan
thrombin
gener
fibrin
neonh
terminu
fibrin
b
chain
defin
residu
particip
clot
format
also
implic
number
import
cellular
respons
includ
cell
spread
stimul
cell
prolifer
bind
vecadherin
support
angiogenesi
bind
endotheli
cell
hspg
induc
cell
migrat
wound
repair
shown
cryptic
heparan
bind
domain
map
b
residu
fibrin
ogen
vecadherin
bind
domain
heparan
bind
domain
fibrin
ogen
overlap
fibrinogen
b
chain
rule
possibl
endotheli
cell
surfac
hspg
play
role
intact
fibrinogeninduc
endotheli
permeabl
howev
consid
least
favor
interpret
data
heparindepend
bind
letter
editor
fibrin
monom
endotheli
cell
occur
endotheli
cell
fix
elisa
plate
cell
bind
assay
contrast
fibrinogen
bound
poorli
fix
endotheli
cell
cell
bind
assay
furthermor
shown
fibrinogen
assembl
extracellular
matrix
requir
bind
cell
surfac
deposit
matrix
pleas
see
fig
ref
cell
surfac
bind
integrin
depend
requir
fibrinogen
aachain
rgd
sequenc
howev
cell
surfac
bind
hspg
depend
desbb
fibrinogen
also
known
still
assembl
matrix
fibril
pleas
see
fig
ref
moreov
metabol
activ
cell
capabl
assembl
fibrinogen
matur
matrix
fibril
pleas
see
fig
ref
taken
togeth
publish
data
support
conclus
absenc
malign
breast
cancer
cell
endotheli
barrier
permeabl
occur
intact
fibrinogen
bind
integrin
endotheli
cell
surfac
bind
induc
conform
chang
expos
fibrinogen
b
domain
thu
allow
bind
vecadherin
conclus
support
photomicrograph
fig
cover
photo
sahni
et
al
show
fibrinogen
assembl
subendotheli
matrix
fibril
bind
surfac
endotheli
cell
celltocel
junction
vecadherin
found
agre
fibrin
thrombin
play
signific
physiolog
role
cancer
metastasi
howev
exact
structur
fibrin
ogen
fibrin
ogen
degrad
product
promot
endotheli
barrier
permeabl
poorli
understood
pose
intrigu
possibl
subphysiolog
level
fibrinogen
modul
cell
respons
microenviron
fibrinogen
tumor
cell
endothelium
interact
extens
research
laboratori
contribut
elucid
molecular
mechan
regul
gene
express
protein
biosynthesi
assembl
function
fibrinogen
produc
extrahepat
epithelium
lung
prostat
breast
use
adenocarcinoma
cell
line
other
report
express
fibrinogen
gene
secret
fibrinogen
protein
intestin
cervic
epitheli
cancer
cell
line
extrahepat
express
fibrinogen
occur
vivo
demonstr
anim
model
pneumocysti
carinii
pneumonia
gene
express
profil
biopsi
sampl
patient
lung
breast
cancer
function
signific
fibrinogen
express
extrahepat
epithelium
like
influenc
cellular
context
fibrinogen
found
rather
overal
plasma
concentr
summari
stand
interpret
exposur
vecadherin
bind
domain
intact
fibrinogen
induc
endotheli
cell
permeabl
promot
transendotheli
migrat
malign
breast
cancer
cell
vitro
furthermor
reason
hypothes
small
amount
fibrinogen
produc
endogen
breast
cancer
cell
contribut
tumor
cellendotheli
cell
interact
promot
breast
cancer
metastasi
vivo
strike
observ
intact
fibrinogen
unabl
induc
barrier
endotheli
permeabl
presenc
nonmalign
breast
epitheli
cell
pleas
see
fig
discuss
ref
led
us
hypothes
nonmalign
breast
epitheli
cell
bind
fibrinogen
b
sequenc
like
cell
surfac
hspg
render
vecadherin
bind
domain
fibrinogen
b
inaccess
abil
nonmalign
breast
epitheli
cell
bind
fibrinogen
b
loss
bind
capac
malign
breast
cancer
cell
suggest
molecular
mechan
premalign
breast
epitheli
cell
transform
highli
aggress
metastat
breast
cancer
phenotyp
studi
anim
model
breast
cancer
metastasi
permit
us
test
valid
hypothes
